Acura Pharmaceuticals (OTCMKTS:ACUR) Stock Crosses Above Two Hundred Day Moving Average – What’s Next?

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) shares crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.0003. Acura Pharmaceuticals shares last traded at $0.0003, with a volume of 4,900 shares.

Acura Pharmaceuticals Trading Up 50.0%

About Acura Pharmaceuticals

Acura Pharmaceuticals Inc is a specialty pharmaceutical company focused on developing and commercializing products designed to deter prescription drug abuse and misuse. The company’s core business centers on proprietary drug formulations that incorporate its Aversion and ARCUS® abuse-deterrent technologies. These platforms are intended to make it more difficult to tamper with or extract active pharmaceutical ingredients from oral dosage forms, helping to address public health concerns around opioid and stimulant abuse.

Acura’s lead product, Oxaydo®, is an immediate‐release oxycodone tablet that employs Aversion® technology to discourage tampering and intravenous abuse.